News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Leavitt Chase C.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Leavitt Chase C. (General Counsel/Secretary) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Disposed/sold 65,000 options
@ $6.46, valued at
$419.9k
Disposed/sold 55,519 options
@ $1.94, valued at
$107.7k
Disposed/sold 28,750 options
@ $1.04, valued at
$29.9k
Disposed/sold 210,000 options
@ $0.96, valued at
$201.6k
Granted 65,000 options
@ $0
Granted 55,519 options
@ $0
Granted 28,750 options
@ $0
Granted 210,000 options
@ $0
Granted 235,000 options
@ $0.31, valued at
$72.9k
|
|
| 07/05/2023 |
4
| Leavitt Chase C. (General Counsel/Secretary) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 10,305 shares
@ $0.36, valued at
$3.7k
|
|
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2023 |
4
| Leavitt Chase C. (General Counsel/Secretary) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 210,000 options
@ $0.96, valued at
$201.6k
|
|
| 01/05/2023 |
4
| Leavitt Chase C. (General Counsel/Secretary) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 6,091 shares
@ $1.02, valued at
$6.2k
|
|
| 08/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2022 |
4
| Leavitt Chase C. (General Counsel/Secretary) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Bought 8,500 shares
@ $1.78, valued at
$15.1k
Bought 5,000 shares
@ $1.63, valued at
$8.2k
|
|
| 01/24/2022 |
4
| Leavitt Chase C. (General Counsel/Secretary) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 55,519 options
@ $1.94, valued at
$107.7k
|
|
| 01/05/2022 |
4
| Leavitt Chase C. (General Counsel/Secretary) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 29,867 shares
@ $0 |
|
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2020 |
4
| Leavitt Chase C. (General Counsel/Secretary) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 616,700 options to buy
@ $0.6919, valued at
$426.7k
|
|
| 08/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/22/2019 |
4
| Leavitt Chase C. (General Counsel/Secretary) has filed a Form 4 on BIOTIME INC|
Txns:
| Granted 300,000 options to buy
@ $1.13, valued at
$339k
|
|
| 05/22/2019 |
3
| Leavitt Chase C. (General Counsel/Secretary) has filed a Form 3 on BIOTIME INC |
|
|